Detailed Information on Publication Record
2007
Klinický význam 18-F-FDG-pozitronové emisní tomografie u folikulárního lymfomu
JANÍKOVÁ, Andrea, Karel BOLČÁK, Jiří MAYER, Danka HARUŠTIAKOVÁ, Jaroslav STANÍČEK et. al.Basic information
Original name
Klinický význam 18-F-FDG-pozitronové emisní tomografie u folikulárního lymfomu
Name in Czech
Klinický význam 18-F-FDG-pozitronové emisní tomografie u folikulárního lymfomu
Name (in English)
Clinical value of FDG - PET in follicular lymfoma
Authors
JANÍKOVÁ, Andrea (203 Czech Republic, guarantor, belonging to the institution), Karel BOLČÁK (203 Czech Republic), Jiří MAYER (203 Czech Republic, belonging to the institution), Danka HARUŠTIAKOVÁ (703 Slovakia, belonging to the institution) and Jaroslav STANÍČEK (203 Czech Republic)
Edition
XXI. Olomoucké hematologické dny s mezinárodní účastí, 2007
Other information
Language
Czech
Type of outcome
Konferenční abstrakt
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
RIV identification code
RIV/00216224:14110/07:00041703
Organization unit
Faculty of Medicine
ISBN
978-80-7346-078-5
Keywords in English
PET; follicular lymfoma
Tags
Změněno: 29/4/2011 10:52, prof. RNDr. Luděk Bláha, Ph.D.
V originále
18F-FDG-positron emission tomography (PET) appears to be highly sensitive and specific in follicular lymphoma (FL). By contrast its usefulness in FL has not clearly been defined. We wanted to evaluate role of PET in staging and restaging of this disease. PET may ontribute to the management of patients with follicular lymphoma, in the staging it can often substantially change treatment strategy. PET-positivity after treatment predicts high risk of early relaps and can identify patients with poor prognosis.
In English
18F-FDG-positron emission tomography (PET) appears to be highly sensitive and specific in follicular lymphoma (FL). By contrast its usefulness in FL has not clearly been defined. We wanted to evaluate role of PET in staging and restaging of this disease. PET may ontribute to the management of patients with follicular lymphoma, in the staging it can often substantially change treatment strategy. PET-positivity after treatment predicts high risk of early relaps and can identify patients with poor prognosis.
Links
MSM0021622412, plan (intention) |
|